Go Pro
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free TRLS Stock Alerts

Trellus Health (TRLS) Competitors

GBX 0.12 0.00 (0.00%)
As of 08/20/2026
Compare

TRLS vs. IQAI, DVRG, SENS, EMIS, and CRW

Should you buy Trellus Health stock or one of its competitors? Trellus Health's main competitors and comparable companies include IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), and Craneware (CRW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Trellus Health compare to IQ-AI?

IQ-AI (LON:IQAI) and Trellus Health (LON:TRLS) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, profitability, analyst recommendations, institutional ownership, valuation and dividends.

In the previous week, Trellus Health had 1 more articles in the media than IQ-AI. MarketBeat recorded 1 mentions for Trellus Health and 0 mentions for IQ-AI. IQ-AI's average media sentiment score of 0.00 equaled Trellus Health'saverage media sentiment score.

Company Overall Sentiment
IQ-AI Neutral
Trellus Health Neutral

IQ-AI has a beta of 2.25, suggesting that its share price is 125% more volatile than the broader market. Comparatively, Trellus Health has a beta of 2.509, suggesting that its share price is 151% more volatile than the broader market.

IQ-AI has higher revenue and earnings than Trellus Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IQ-AI£538.19K3.30N/AN/AN/A
Trellus Health£359K1.44-£7.98M-£5.00N/A

IQ-AI has a net margin of -77.52% compared to Trellus Health's net margin of -6,826.32%. Trellus Health's return on equity of -49.78% beat IQ-AI's return on equity.

Company Net Margins Return on Equity Return on Assets
IQ-AI-77.52% -140.75% -22.03%
Trellus Health -6,826.32%-49.78%-22.76%

1.6% of Trellus Health shares are owned by institutional investors. 66.0% of IQ-AI shares are owned by insiders. Comparatively, 9.6% of Trellus Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

IQ-AI and Trellus Health tied by winning 5 of the 10 factors compared between the two stocks.

How does Trellus Health compare to DeepVerge?

DeepVerge (LON:DVRG) and Trellus Health (LON:TRLS) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, media sentiment, profitability, institutional ownership, risk, dividends and earnings.

DeepVerge has a net margin of -19.81% compared to Trellus Health's net margin of -6,826.32%. DeepVerge's return on equity of -10.27% beat Trellus Health's return on equity.

Company Net Margins Return on Equity Return on Assets
DeepVerge-19.81% -10.27% -5.56%
Trellus Health -6,826.32%-49.78%-22.76%

4.2% of DeepVerge shares are owned by institutional investors. Comparatively, 1.6% of Trellus Health shares are owned by institutional investors. 9.5% of DeepVerge shares are owned by insiders. Comparatively, 9.6% of Trellus Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

DeepVerge has higher revenue and earnings than Trellus Health. Trellus Health is trading at a lower price-to-earnings ratio than DeepVerge, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DeepVerge£12.41M0.00-£2.46M-£0.01N/A
Trellus Health£359K1.44-£7.98M-£5.00N/A

DeepVerge has a beta of 1.07, meaning that its stock price is 7% more volatile than the broader market. Comparatively, Trellus Health has a beta of 2.509, meaning that its stock price is 151% more volatile than the broader market.

In the previous week, Trellus Health had 1 more articles in the media than DeepVerge. MarketBeat recorded 1 mentions for Trellus Health and 0 mentions for DeepVerge. DeepVerge's average media sentiment score of 0.00 equaled Trellus Health'saverage media sentiment score.

Company Overall Sentiment
DeepVerge Neutral
Trellus Health Neutral

Summary

DeepVerge beats Trellus Health on 7 of the 11 factors compared between the two stocks.

How does Trellus Health compare to Sensyne Health?

Trellus Health (LON:TRLS) and Sensyne Health (LON:SENS) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability.

Sensyne Health has a net margin of 0.00% compared to Trellus Health's net margin of -6,826.32%. Sensyne Health's return on equity of 0.00% beat Trellus Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Trellus Health-6,826.32% -49.78% -22.76%
Sensyne Health N/A N/A N/A

1.6% of Trellus Health shares are held by institutional investors. 9.6% of Trellus Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Sensyne Health has higher revenue and earnings than Trellus Health. Trellus Health is trading at a lower price-to-earnings ratio than Sensyne Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trellus Health£359K1.44-£7.98M-£5.00N/A
Sensyne Health£7.81M0.00N/A-£22.10N/A

In the previous week, Trellus Health had 1 more articles in the media than Sensyne Health. MarketBeat recorded 1 mentions for Trellus Health and 0 mentions for Sensyne Health. Trellus Health's average media sentiment score of 0.00 equaled Sensyne Health'saverage media sentiment score.

Company Overall Sentiment
Trellus Health Neutral
Sensyne Health Neutral

Summary

Sensyne Health beats Trellus Health on 5 of the 9 factors compared between the two stocks.

How does Trellus Health compare to EMIS Group?

Trellus Health (LON:TRLS) and EMIS Group (LON:EMIS) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, media sentiment, valuation and earnings.

In the previous week, Trellus Health had 1 more articles in the media than EMIS Group. MarketBeat recorded 1 mentions for Trellus Health and 0 mentions for EMIS Group. Trellus Health's average media sentiment score of 0.00 equaled EMIS Group'saverage media sentiment score.

Company Overall Sentiment
Trellus Health Neutral
EMIS Group Neutral

EMIS Group has higher revenue and earnings than Trellus Health. Trellus Health is trading at a lower price-to-earnings ratio than EMIS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trellus Health£359K1.44-£7.98M-£5.00N/A
EMIS Group£176.86M0.00£30.48M£0.47N/A

Trellus Health has a beta of 2.509, indicating that its stock price is 151% more volatile than the broader market. Comparatively, EMIS Group has a beta of -0.13, indicating that its stock price is 113% less volatile than the broader market.

1.6% of Trellus Health shares are owned by institutional investors. Comparatively, 105.6% of EMIS Group shares are owned by institutional investors. 9.6% of Trellus Health shares are owned by insiders. Comparatively, 3.6% of EMIS Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

EMIS Group has a net margin of 17.23% compared to Trellus Health's net margin of -6,826.32%. EMIS Group's return on equity of 23.17% beat Trellus Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Trellus Health-6,826.32% -49.78% -22.76%
EMIS Group 17.23%23.17%7.99%

Summary

EMIS Group beats Trellus Health on 8 of the 11 factors compared between the two stocks.

How does Trellus Health compare to Craneware?

Craneware (LON:CRW) and Trellus Health (LON:TRLS) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.

Craneware has higher revenue and earnings than Trellus Health. Trellus Health is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Craneware£211.33M2.10£14.27M£62.9020.60
Trellus Health£359K1.44-£7.98M-£5.00N/A

Craneware has a net margin of 10.63% compared to Trellus Health's net margin of -6,826.32%. Craneware's return on equity of 6.65% beat Trellus Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Craneware10.63% 6.65% 2.28%
Trellus Health -6,826.32%-49.78%-22.76%

35.7% of Craneware shares are owned by institutional investors. Comparatively, 1.6% of Trellus Health shares are owned by institutional investors. 10.3% of Craneware shares are owned by insiders. Comparatively, 9.6% of Trellus Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Craneware has a beta of 0.28, suggesting that its share price is 72% less volatile than the broader market. Comparatively, Trellus Health has a beta of 2.509, suggesting that its share price is 151% more volatile than the broader market.

Craneware presently has a consensus price target of GBX 2,222.75, indicating a potential upside of 71.53%. Given Craneware's stronger consensus rating and higher possible upside, equities research analysts plainly believe Craneware is more favorable than Trellus Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Craneware
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
Trellus Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Trellus Health had 1 more articles in the media than Craneware. MarketBeat recorded 1 mentions for Trellus Health and 0 mentions for Craneware. Craneware's average media sentiment score of 0.00 equaled Trellus Health'saverage media sentiment score.

Company Overall Sentiment
Craneware Neutral
Trellus Health Neutral

Summary

Craneware beats Trellus Health on 13 of the 15 factors compared between the two stocks.

Get Trellus Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRLS vs. The Competition

Export
MetricTrellus HealthHealthcare Technology IndustryHealthcare SectorLON Exchange
Market Cap£516K£1.72B£7.32B£2.90B
Dividend YieldN/A4.69%2.54%6.17%
P/E Ratio-0.0221.45272.92367.68
Price / Sales1.4476.07635.9383,309.11
Price / Cash0.7631.6929.0327.89
Price / Book0.015.7811.267.27
Net Income-£7.98M-£18.66M£3.47B£5.89B
7 Day PerformanceN/A1.85%2.35%0.57%
1 Month PerformanceN/A12.87%7.74%3.17%
1 Year Performance-81.54%-16.99%25.22%22.21%

Trellus Health Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRLS
Trellus Health
N/AGBX 0.12
flat		N/AN/A£516K£359KN/A31
IQAI
IQ-AI
N/AGBX 0.80
flat		N/A+0.0%£1.77M£538.19KN/A6
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41MN/A73
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81MN/A70
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:TRLS) was last updated on 8/24/2026 by MarketBeat.com Staff.
From Our Partners
A Simple Guide to Options Trading While It's Still Free
A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...
True Market Insiders | Sponsoredtc pixel
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
These gold assets are priced for $1,800 gold [it's over $4,000]
Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...
Golden Portfolio | Sponsoredtc pixel
A $382 trillion migration and the position no one is talking about
Trump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...
Awesomely | Sponsoredtc pixel
Bank of America grew this stake 139%
Bank of America raised its stake in a small gold company by 139%. Jane Street increased its position by 159%, ...
Behind the Markets | Sponsoredtc pixel
Free Stock Pick: The Company First in Line for America’s New Super Fuel
The U.S. Army and Department of Energy are launching Project Janus - a high-priority initiative ordered by Pre...
Banyan Hill Publishing | Sponsoredtc pixel
Your withdrawal order could cost you in taxes
If you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...
SmartAsset | Sponsoredtc pixel
The Musk-linked sector everyone's sleeping on
Micron, a key Musk supplier, surged 1,121% in under two years after Jeff Brown flagged it early. Now Brown ...
Brownstone Research | Sponsoredtc pixel